208 related articles for article (PubMed ID: 6968912)
1. Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin.
Krolick KA; Villemez C; Isakson P; Uhr JW; Vitetta ES
Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5419-23. PubMed ID: 6968912
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of a murine B cell tumor with antibodies and F(ab')2 fragments against idiotypic determinants of its cell surface IgM.
Perek Y; Hurwitz E; Burowski D; Haimovich J
J Immunol; 1983 Sep; 131(3):1600-3. PubMed ID: 6604103
[TBL] [Abstract][Full Text] [Related]
3. Selective in vitro inhibition of an antibody response to purified acetylcholine receptor by using anti-idiotypic antibodies coupled to the A chain of ricin.
DeShambo RM; Krolick KA
J Immunol; 1986 Nov; 137(10):3135-9. PubMed ID: 3490511
[TBL] [Abstract][Full Text] [Related]
4. Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin.
Youle RJ; Neville DM
Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5483-6. PubMed ID: 6968914
[TBL] [Abstract][Full Text] [Related]
5. Xid and normal mice express a light chain-associated cross-reactive idiotype in response to (T,G)-A--L and (T,G)-A--L-mBSA.
Busto P; Giorgetti CA; Gawoski J; Press JL
J Immunol; 1986 May; 136(10):3734-43. PubMed ID: 3084642
[TBL] [Abstract][Full Text] [Related]
6. Whole ricin and recombinant ricin A chain idiotype-specific immunotoxins for therapy of the guinea pig L2C B cell leukemia.
Gregg EO; Bridges SH; Youle RJ; Longo DL; Houston LL; Glennie MJ; Stevenson FK; Green I
J Immunol; 1987 Jun; 138(12):4502-8. PubMed ID: 3495593
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
Ciavarra RP; Vitetta ES; Forman J
J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
[TBL] [Abstract][Full Text] [Related]
8. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
George AJ; Tutt AL; Stevenson FK
J Immunol; 1987 Jan; 138(2):628-34. PubMed ID: 3491853
[TBL] [Abstract][Full Text] [Related]
9. Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells.
King CA; Wills MR; Hamblin TJ; Stevenson FK
Cell Immunol; 1993 Apr; 147(2):411-24. PubMed ID: 8095858
[TBL] [Abstract][Full Text] [Related]
10. Idiotypic analysis of a B cell clone with anti-intermediate filament specificity in a patient with Sjögren's syndrome: involvement of five subpopulations producing different immunoglobulin isotypes.
Landay A; Kubagawa H; Cooper MD
J Immunol; 1986 Jul; 137(1):129-36. PubMed ID: 3086445
[TBL] [Abstract][Full Text] [Related]
11. Production of mouse monoclonal antibodies for the analysis of idiotypes in serum of patients with chronic lymphatic leukaemia.
de Rie MA; van Heemstra DJ; Huijgens PC; Zeijlemaker WP; Out TA; Melief CJ; von dem Borne AE
Br J Haematol; 1988 Jan; 68(1):11-6. PubMed ID: 3257881
[TBL] [Abstract][Full Text] [Related]
12. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
Tamura GS; McGrath MS; Weissman IL
J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties.
Goroff DK; Stall A; Mond JJ; Finkelman FD
J Immunol; 1986 Apr; 136(7):2382-92. PubMed ID: 2419432
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody.
Vitetta ES; Yuan D; Krolick K; Isakson P; Knapp M; Slavin S; Strober S
J Immunol; 1979 May; 122(5):1649-54. PubMed ID: 109513
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of ricin A chain-containing immunotoxins directed against different epitopes on the delta-chain of cell surface-associated IgD on murine B cells.
May RD; Finkelman FD; Wheeler HT; Uhr JW; Vitetta ES
J Immunol; 1990 May; 144(9):3637-42. PubMed ID: 1691764
[TBL] [Abstract][Full Text] [Related]
16. Permanent alteration of the murine Ly-1 B repertoire due to selective depletion of Ly-1 B cells in neonatal animals.
Lalor PA; Stall AM; Adams S; Herzenberg LA
Eur J Immunol; 1989 Mar; 19(3):501-6. PubMed ID: 2785045
[TBL] [Abstract][Full Text] [Related]
17. Induction and suppression of polyclonal antibody responses by anti-Ig reagents and antigen-nonspecific helper factors: a comparison of the effects of anti-Fab, anti-IgM, and anti IgD on murine B cells.
Parker DC
Immunol Rev; 1980; 52():115-39. PubMed ID: 7021394
[No Abstract] [Full Text] [Related]
18. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
[TBL] [Abstract][Full Text] [Related]
19. In vivo therapy of the BCL1 tumor: effect of immunotoxin valency and deglycosylation of the ricin A chain.
Fulton RJ; Uhr JW; Vitetta ES
Cancer Res; 1988 May; 48(9):2626-31. PubMed ID: 3258547
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the reactivity of four anti-mouse IgM allotype antibodies with mu+ B lineage cells at various stages of differentiation.
Velardi A; Kubagawa H; Kearney JF
J Immunol; 1984 Oct; 133(4):2098-103. PubMed ID: 6432906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
